Literature DB >> 1977359

In vivo evidence for the existence of autoreceptors on dopaminergic, serotonergic, and cholinergic neurons in the brain.

B H Westerink1, P De Boer, W Timmerman, J B De Vries.   

Abstract

Intrastriatal infusions as well as systemic administration of the selective D-2 antagonist (-)-sulpiride caused similar increases in the dialysate levels of dopamine (DA) to about 180% of controls. A similar conclusion was drawn when the selective D-2 agonist (-)-N-0437 was infused intrastriatally or administered systemically: both routes of administration caused a decrease in the release of DA to about 40-50% of controls. In order to evaluate the properties of synthesis-modulating autoreceptors on dopaminergic and serotonergic neurons we have estimated the synthesis rate of serotonin (5-HT) or DA by monitoring the 5-HTP or DOPA formation in the dialysates during infusion of a decarboxylase inhibitor. Infusion of (-)-N-0437 decreased the DOPA formation, whereas infusion of (-)-sulpiride increased the dialysate levels of DOPA; these results indicate that the D-2 receptors controlling the synthesis of DA are localized on nerve terminals. Administration of the selective 5-HT-IA agonist 8-hydroxy-dipropyl-aminotetraline (8-OH-DPAT) resulted in a decrease in the synthesis rate of 5-HT. When 8-OH-DPAT was infused via the dialysis membrane, the agonist was unable to modify the release of 5-HT. The effects of infusion of the muscarinic agonist oxotremorine and the muscarinic antagonist atropine were dependent on the presence of the esterase inhibitor neostigmine in the perfusion fluid. In the absence of neostigmine, oxotremorine caused a pronounced decrease in the output of acetylcholine (ACh), whereas atropine was without effect. In the presence of neostigmine oxotremorine was without effect but infusion of atropine or other anticholinergics caused a pronounced increase in the dialysate levels of ACh. It is concluded that the autoreceptor controlling the release of ACh is of the M3-type and that the receptor is not fully occupied during normal conditions. In conclusion, microdialysis of neurotransmitters is a valuable tool for the study of autoreceptors in vivo. The presented studies provided evidence for the existence of autoreceptors controlling the synthesis and/or release of DA, 5-HT, as well as ACh in the striatum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977359     DOI: 10.1111/j.1749-6632.1990.tb32015.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Dietary supplementation with uridine-5'-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat.

Authors:  Lei Wang; Meredith A Albrecht; Richard J Wurtman
Journal:  Brain Res       Date:  2006-12-19       Impact factor: 3.252

2.  In vivo microdialysis of noradrenaline overflow: effects of alpha-adrenoceptor agonists and antagonists measured by cumulative concentration-response curves.

Authors:  M J van Veldhuizen; M G Feenstra; R P Heinsbroek; G J Boer
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

3.  Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.

Authors:  George E Jaskiw; Bobbi Kirkbride; Erica Newbould; Damon Young; Valerie Durkalski; Rodolfo Bongiovanni
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

4.  Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy.

Authors:  Christian R Burgess; Gavin Tse; Lauren Gillis; John H Peever
Journal:  Sleep       Date:  2010-10       Impact factor: 5.849

5.  D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells.

Authors:  E N Pothos; S Przedborski; V Davila; Y Schmitz; D Sulzer
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

6.  Towards a reconceptualization of striatal interactions between glutamatergic and dopaminergic neurotransmission and their contribution to the production of movements.

Authors:  Hélène N David
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.